Now, in my experience, changes are being made, and, since the authorizationform was signed days before, the final return submitted may be significantly different from what the client saw.
The FDA approved Kynamro with a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use, including prescriber and pharmacy certification, and documentation of safe-use conditions, which requires a prescription authorizationform for each new prescription.